Patents and litigation

January 15, 2019

Boston and Edwards make a smart judgement

The immensely complex and long-running intertwined litigation between the two medtechs has been brought to an end.

September 11, 2018

No margin left for error at Acorda

Generic versions of Acorda’s Ampyra are about to flood the market, meaning that the company desperately needs a timely approval in October for its next big hope.

April 03, 2017

Patent rulings knock Acorda and Forward

Acorda and Forward have been bashed by unfavourable US patent verdicts in multiple sclerosis, while Steadymed got a boost.

Patents and litigation

Boston and Edwards make a smart judgement

No margin left for error at Acorda

Patent rulings knock Acorda and Forward

Latest Reports

Vantage Pharma, Biotech and Medtech 2018 in Review

Vantage 2019 Preview

Editor's Picks

Asco 2019 – Abstract drop fires the starting gun

Who will capitalise on CAR-T at last? Not big pharma, says Tmunity

Price fixing case caps a terrible week for generics

Astra makes machine learning bet with Benevolent AI deal

Looking back at April’s data digging and analysis